Identification of Biomarkers Including 18FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Olivier,Humbert ^[1] ; Jean-Marc,Riedinger ^[2] ; Céline,Charon-Barra ^[3] ; Alina,Berriolo-Riedinger ^[4] ; Isabelle,Desmoulins ^[5] ; Véronique,Lorgis ^[5] ; Salim,Kanoun ^[6] ; Charles,Coutant ^[7] ; Pierre,Fumoleau ^[5] ; Alexandre,Cochet ^[8] ; François,Brunotte ^[6]

作者单位： Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France. Université de Bourgogne, UMR CNRS 6306, Dijon, France. ohumbert@cgfl.fr. ^[1] Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France. Departments of Biology and Pathology, Centre GF Leclerc, Dijon, France. ^[2] Departments of Biology and Pathology, Centre GF Leclerc, Dijon, France. ^[3] Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France. ^[4] Department of Medical Oncology, Centre GF Leclerc, Dijon, France. ^[5] Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France. Université de Bourgogne, UMR CNRS 6306, Dijon, France. Imaging Department, CHU Le Bocage, Dijon, France. ^[6] Department of Surgery, Centre GF Leclerc, Dijon, France. ^[7] Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France. Université de Bourgogne, UMR CNRS 6306, Dijon, France. ^[8]